Glycyrrhetinic acid modified MOFs for the treatment of liver cancer.
Li L, Han S, Yang C, Liu L, Zhao S, Wang X, Liu B, Pan H, Liu Y.
Li L, et al. Among authors: liu y, liu l, liu b.
Nanotechnology. 2020 Aug 7;31(32):325602. doi: 10.1088/1361-6528/ab8c03. Epub 2020 Apr 22.
Nanotechnology. 2020.
PMID: 32320964